Lawrence Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lawrence Nelson has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
D.E. Koziol
Section on Women’s Health Research DEB,NICHD,NIH, Bethesda, MD; Dept of Psychology, Arizona State Univ, Tempe, AZ; Pharmacy Dept, NIH Clinical Research Center, Bethesda, MD; Biostatistics & Clinical Epidemiology Services, NIH Clinical Research Center, Bethesda, MD; Section on Women’s Health Research DEB,NICHD, NIH, Bethesda, MD; Section on Women’s Health Research DEB, NICHD, NIH, Bethesda, MD
1 shared publication- Evelina Sterling
Kennesaw State University
1 shared publication - Heather Chapin
Department of Anesthesia, Stanford University, Palo Alto, CA, United States
1 shared publication J.L. Ventura
Section on Women’s Health Research DEB,NICHD,NIH, Bethesda, MD; Dept of Psychology, Arizona State Univ, Tempe, AZ; Pharmacy Dept, NIH Clinical Research Center, Bethesda, MD; Biostatistics & Clinical Epidemiology Services, NIH Clinical Research Center, Bethesda, MD; Section on Women’s Health Research DEB,NICHD, NIH, Bethesda, MD; Section on Women’s Health Research DEB, NICHD, NIH, Bethesda, MD
1 shared publication- Jennifer D. Merrill
Department of Medicine, Blanchard Valley Health System , Findlay, OH 45840
1 shared publication K.A. Calis
Section on Women’s Health Research DEB,NICHD,NIH, Bethesda, MD; Dept of Psychology, Arizona State Univ, Tempe, AZ; Pharmacy Dept, NIH Clinical Research Center, Bethesda, MD; Biostatistics & Clinical Epidemiology Services, NIH Clinical Research Center, Bethesda, MD; Section on Women’s Health Research DEB,NICHD, NIH, Bethesda, MD; Section on Women’s Health Research DEB, NICHD, NIH, Bethesda, MD
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (7) , 3899-3904
Women’s hormonal health research and care: the times, they are a-changin’
Editorial Commentary Women’s hormonal health research and care: the times, they are a-changin’ Jennifer D. Merrill, Lawrence M. Nelson
- 1 January 2023
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (7) , 3899-3904
Open AccessWomen’s hormonal health research and care: the times, they are a-changin’
Editorial Commentary Women’s hormonal health research and care: the times, they are a-changin’ Jennifer D. Merrill, Lawrence M. Nelson
- Open Access
- 1 July 2011
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 29 (04) , 353-361
From Victim to Survivor to Thriver: Helping Women with Primary Ovarian Insufficiency Integrate Recovery, Self-Management, and Wellness
Most women discover that they are infertile in a gradual manner after many failed attempts at conception. By contrast, most women with primary ovarian insufficiency (POI) uncover their infertility as part of an evaluation of other presenting complaints, frequently before attempts at conception have even been contemplated. The most common words women use to describe how they feel in the hours after getting the diagnosis of POI are “devastated,” “shocked,” and “confused.” Clearly, the news propels some patients onto a difficult journey. POI is a serious and incurable chronic disease. The diagnosis is more than infertility and affects a woman's physical and emotional well-being. Management of the condition must address both. Patients face the acute shock of the diagnosis, associated stigma of infertility, grief from the death of dreams, anxiety from the disruption of life plans, confusion around the cause, symptoms of estrogen deficiency, worry over the associated potential medical sequelae such as reduced bone density and cardiovascular risk, and the uncertain future that all of these factors create. There is a need for an evidenced-based integrated program to assist women with POI in navigating the transition to acceptance of the diagnosis, ongoing management of the condition, and ongoing maintenance of wellness in the presence of the disorder. A health-centered approach can gradually replace the disease-centered approach and put patients in partnerships with professional health-care providers. Ideally, the journey transitions each patient from seeing herself as a victim, to a survivor, to a woman who is thriving.
- 1 July 2011
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 29 (04) , 353-361
Open AccessFrom Victim to Survivor to Thriver: Helping Women with Primary Ovarian Insufficiency Integrate Recovery, Self-Management, and Wellness
Most women discover that they are infertile in a gradual manner after many failed attempts at conception. By contrast, most women with primary ovarian insufficiency (POI) uncover their infertility as part of an evaluation of other presenting complaints, frequently before attempts at conception have even been contemplated. The most common words women use to describe how they feel in the hours after getting the diagnosis of POI are “devastated,” “shocked,” and “confused.” Clearly, the news propels some patients onto a difficult journey. POI is a serious and incurable chronic disease. The diagnosis is more than infertility and affects a woman's physical and emotional well-being. Management of the condition must address both. Patients face the acute shock of the diagnosis, associated stigma of infertility, grief from the death of dreams, anxiety from the disruption of life plans, confusion around the cause, symptoms of estrogen deficiency, worry over the associated potential medical sequelae such as reduced bone density and cardiovascular risk, and the uncertain future that all of these factors create. There is a need for an evidenced-based integrated program to assist women with POI in navigating the transition to acceptance of the diagnosis, ongoing management of the condition, and ongoing maintenance of wellness in the presence of the disorder. A health-centered approach can gradually replace the disease-centered approach and put patients in partnerships with professional health-care providers. Ideally, the journey transitions each patient from seeing herself as a victim, to a survivor, to a woman who is thriving.
- Open Access
- 1 July 2011
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 29 (04) , 308-316
Mechanisms and Models of Immune Tolerance Breakdown in the Ovary
Ovarian autoimmunity is increasingly implicated in the etiology of primary ovarian insufficiency (POI), previously termed premature ovarian failure or premature menopause. Links to autoimmunity in human POI have long been noted due to the close association of POI with several autoimmune diseases and syndromes such as Addison's disease and Autoimmune polyglandular syndrome 1. However, diagnosis of autoimmune-mediated POI (aPOI) remains challenging because of the lack of sensitive or specific markers of disease. Autoimmunity can arise from the breakdown of immunological tolerance in several ways. How then may we discern what constitutes a relevant target and what represents a downstream phenomenon? The answer lies in the study of pathogenic mechanisms in translational models of disease. From examples in humans and mice, we see that ovarian autoimmunity likely arises from a limited number of antigens targeted in the ovary that are organ specific. These antigens may be conserved but not limited to those seen in animal models of autoimmune ovarian disease. Recent advances in these areas have begun to define the relevant antigens and mechanisms of immune tolerance breakdown in the ovary. Work in translational models continues to provide insight into mechanisms of disease pathogenesis that will allow more accurate diagnosis and, ultimately, improved interventions for women with aPOI.
- 1 July 2011
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 29 (04) , 308-316
Open AccessMechanisms and Models of Immune Tolerance Breakdown in the Ovary
Ovarian autoimmunity is increasingly implicated in the etiology of primary ovarian insufficiency (POI), previously termed premature ovarian failure or premature menopause. Links to autoimmunity in human POI have long been noted due to the close association of POI with several autoimmune diseases and syndromes such as Addison's disease and Autoimmune polyglandular syndrome 1. However, diagnosis of autoimmune-mediated POI (aPOI) remains challenging because of the lack of sensitive or specific markers of disease. Autoimmunity can arise from the breakdown of immunological tolerance in several ways. How then may we discern what constitutes a relevant target and what represents a downstream phenomenon? The answer lies in the study of pathogenic mechanisms in translational models of disease. From examples in humans and mice, we see that ovarian autoimmunity likely arises from a limited number of antigens targeted in the ovary that are organ specific. These antigens may be conserved but not limited to those seen in animal models of autoimmune ovarian disease. Recent advances in these areas have begun to define the relevant antigens and mechanisms of immune tolerance breakdown in the ovary. Work in translational models continues to provide insight into mechanisms of disease pathogenesis that will allow more accurate diagnosis and, ultimately, improved interventions for women with aPOI.
- 1 May 2002
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 99 (5, Part 1) , 720-725
Meeting the Needs of Young Women With Secondary Amenorrhea and Spontaneous Premature Ovarian Failure
OBJECTIVE To investigate the experiences of young women with spontaneous premature ovarian failure with regard to the initial presenting symptom, promptness of diagnosis, and patient education. METHODS We asked 50 patients previously diagnosed with spontaneous premature ovarian failure to participate in a structured interview survey consisting of 38 true-or-false, multiple-choice, and open-ended questions. RESULTS Disturbance in menstrual pattern was the most common initial symptom in the 48 women who completed the interview (44 of 48, 92%). Over half of the 44 women who presented with this complaint reported visiting a clinician's office three or more times before laboratory testing was performed to determine the diagnosis. Over half of them reported seeing three or more different clinicians before diagnosis. In 25% of women it took longer than 5 years for the diagnosis of premature ovarian failure to be established. Patients who spent more than 5 minutes with the clinician discussing the diagnosis were significantly more likely to be satisfied with the manner in which they were informed (P < .001). Ninety percent of participants were college graduates, and 40% had graduate degrees. CONCLUSION Women with spontaneous premature ovarian failure perceived a need for more aggressive evaluation of secondary amenorrhea and oligomenorrhea. Loss of menstrual regularity can be a sign of ovarian insufficiency, and the associated estrogen deficiency is a well-established risk factor for osteoporosis.
- 1 May 2002
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 99 (5, Part 1) , 720-725
Meeting the Needs of Young Women With Secondary Amenorrhea and Spontaneous Premature Ovarian Failure
OBJECTIVE To investigate the experiences of young women with spontaneous premature ovarian failure with regard to the initial presenting symptom, promptness of diagnosis, and patient education. METHODS We asked 50 patients previously diagnosed with spontaneous premature ovarian failure to participate in a structured interview survey consisting of 38 true-or-false, multiple-choice, and open-ended questions. RESULTS Disturbance in menstrual pattern was the most common initial symptom in the 48 women who completed the interview (44 of 48, 92%). Over half of the 44 women who presented with this complaint reported visiting a clinician's office three or more times before laboratory testing was performed to determine the diagnosis. Over half of them reported seeing three or more different clinicians before diagnosis. In 25% of women it took longer than 5 years for the diagnosis of premature ovarian failure to be established. Patients who spent more than 5 minutes with the clinician discussing the diagnosis were significantly more likely to be satisfied with the manner in which they were informed (P < .001). Ninety percent of participants were college graduates, and 40% had graduate degrees. CONCLUSION Women with spontaneous premature ovarian failure perceived a need for more aggressive evaluation of secondary amenorrhea and oligomenorrhea. Loss of menstrual regularity can be a sign of ovarian insufficiency, and the associated estrogen deficiency is a well-established risk factor for osteoporosis.